Aigen Investment Management’s AbbVie ABBV Stock Holding History

Aigen Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,415	Closed	-$2.87M	–	553
2025 Q3	$2.87M	Sell	12,415 -19,918	-62%	-$4.06M	0.44%	34
2025 Q2	$6M	Buy	32,333 +29,662	+1,111%	+$5.51M	0.82%	5
2025 Q1	$560K	Buy	+2,671	New	+$519K	0.09%	325
2024 Q4	–	Sell	-6,132	Closed	-$1.21M	–	698
2024 Q3	$1.21M	Buy	+6,132	New	+$1.14M	0.24%	117
2024 Q2	–	Sell	-13,044	Closed	-$2.38M	–	736
2024 Q1	$2.38M	Buy	13,044 +7,055	+118%	+$1.22M	0.52%	30
2023 Q4	$928K	Sell	5,989 -627	-9%	-$91.4K	0.17%	166
2023 Q3	$986K	Buy	+6,616	New	+$971K	0.19%	164
2023 Q1	–	Sell	-1,281	Closed	-$207K	–	594
2022 Q4	$207K	Sell	1,281 -17,293	-93%	-$2.65M	0.03%	453
2022 Q3	$2.49M	Buy	+18,574	New	+$2.67M	0.36%	78
2022 Q1	–	Sell	-105,880	Closed	-$13.7M	–	507
2021 Q4	$13.7M	Buy	+105,880	New	+$12.5M	0.84%	5
2021 Q3	–	Sell	-15,172	Closed	-$1.71M	–	451
2021 Q2	$1.71M	Buy	+15,172	New	+$1.71M	0.3%	91
2020 Q4	–	Sell	-74,748	Closed	-$6.55M	–	744
2020 Q3	$6.55M	Sell	74,748 -13,674	-15%	-$1.29M	0.84%	6
2020 Q2	$8.68M	Buy	88,422 +36,882	+72%	+$3.25M	1.11%	1
2020 Q1	$3.93M	Buy	+51,540	New	+$4.39M	0.52%	21

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Aigen Investment Management's ABBV Position: Q4 2025 in Review

Aigen Investment Management sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 12,415 shares — an estimated $2.87M sold.

Aigen Investment Management first reported a position in ABBV in Q1 2020 and held it in 14 quarters. The position peaked at $13.7M in Q4 2021. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

Aigen Investment Management reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
Aigen Investment Management sold 12,415 AbbVie shares in Q4 2025, an estimated $2.87M.
Aigen Investment Management first reported a position in AbbVie in Q1 2020 and held it in 14 quarters.
Aigen Investment Management's AbbVie position peaked at $13.7M in Q4 2021.
4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Aigen Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.